13F HOLDINGS REPORT
KCK LTD.
Quarter ended Q4 2024 · Filed January 15, 2025 · Accession 0001012975-25-000044
Total Value
$75.0M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEUROPACE INC | NPCE | 5,270,845 | $59.0M | 78.69% |
| 2 | SIGHT SCIENCES INC | SGHT | 4,374,975 | $15.9M | 21.25% |
| 3 | AILERON THERAPEUTICS INC | RNTX | 22,341 | $51,384 | 0.07% |